La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hong Seng Consolidated Berhad Résultats passés
Passé contrôle des critères 0/6
Hong Seng Consolidated Berhad has been growing earnings at an average annual rate of 22.2%, while the Healthcare industry saw earnings growing at 25.4% annually. Revenues have been growing at an average rate of 33.2% per year.
Informations clés
22.2%
Taux de croissance des bénéfices
35.5%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 31.5% |
Taux de croissance des recettes | 33.2% |
Rendement des fonds propres | -21.9% |
Marge nette | -409.6% |
Dernière mise à jour des bénéfices | 31 Mar 2024 |
Mises à jour récentes des performances passées
Recent updates
Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?
Jun 09Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?
Oct 12Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?
May 11We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt
Jan 27Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching
Jan 04Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings
Nov 30Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns
Oct 26Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely
Aug 31We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease
Aug 09Ventilation des recettes et des dépenses
Comment Hong Seng Consolidated Berhad gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
31 Mar 24 | 15 | -61 | 14 | 0 |
30 Jun 23 | 9 | -27 | 17 | 0 |
31 Mar 23 | 12 | -3 | 19 | 0 |
31 Dec 22 | 126 | 49 | 23 | 0 |
30 Sep 22 | 198 | 97 | 25 | 0 |
30 Jun 22 | 257 | 135 | 24 | 0 |
31 Mar 22 | 258 | 118 | 21 | 0 |
31 Dec 21 | 196 | 82 | 17 | 0 |
30 Sep 21 | 146 | 44 | 12 | 0 |
31 Dec 20 | 27 | -4 | 5 | 0 |
30 Sep 20 | 2 | -7 | 5 | 0 |
30 Jun 20 | 3 | -8 | 4 | 0 |
31 Mar 20 | 4 | -7 | 5 | 0 |
31 Dec 19 | 5 | -7 | 2 | 0 |
30 Sep 19 | 8 | -13 | 4 | 0 |
30 Jun 19 | 10 | -14 | 4 | 0 |
31 Mar 19 | 10 | -13 | 6 | 0 |
31 Dec 18 | 16 | -26 | 6 | 0 |
30 Sep 18 | 24 | -20 | 6 | 0 |
30 Jun 18 | 26 | -24 | 8 | 0 |
31 Mar 18 | 29 | -27 | 9 | 0 |
31 Dec 17 | 27 | -10 | 15 | 0 |
30 Sep 17 | 27 | -12 | 14 | 0 |
30 Jun 17 | 29 | -11 | 14 | 0 |
31 Mar 17 | 30 | -8 | 12 | 0 |
31 Dec 16 | 31 | -8 | 12 | 0 |
30 Sep 16 | 38 | -3 | 14 | 0 |
30 Jun 16 | 39 | 1 | 13 | 0 |
31 Mar 16 | 42 | 2 | 14 | 0 |
31 Dec 15 | 42 | 4 | 14 | 0 |
30 Sep 15 | 39 | -2 | 12 | 0 |
30 Jun 15 | 39 | -5 | 15 | 0 |
31 Mar 15 | 38 | -5 | 16 | 0 |
31 Dec 14 | 36 | -9 | 18 | 0 |
30 Sep 14 | 33 | -2 | 16 | 0 |
30 Jun 14 | 35 | 1 | 16 | 0 |
31 Mar 14 | 34 | 2 | 16 | 0 |
31 Dec 13 | 34 | 4 | 16 | 0 |
30 Sep 13 | 40 | 8 | 18 | 0 |
Des revenus de qualité: HONGSENG is currently unprofitable.
Augmentation de la marge bénéficiaire: HONGSENG is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: HONGSENG is unprofitable, but has reduced losses over the past 5 years at a rate of 22.2% per year.
Accélération de la croissance: Unable to compare HONGSENG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: HONGSENG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-3.6%).
Rendement des fonds propres
ROE élevé: HONGSENG has a negative Return on Equity (-21.92%), as it is currently unprofitable.